Time to consider HPV vaccination after allogeneic stem cell transplantation.
Tedeschi
Sara K
SK
Long- Term Follow-up Transplant Clinic (LTTC), Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232-5505, USA.
Savani
Bipin N
BN
Jagasia
Madan
M
Engelhardt
Brian
B
Anasetti
Claudio
C
Barrett
A John
AJ
Lee
Stephanie
S
D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D014184:Transplantation, Homologous; D055815:Young Adult
D053918:Papillomavirus Vaccines